DSC Equity Fund – Healthcare A

Reference Data

ISIN AT0000A0XMM2
Valor Number 19994591
Bloomberg Global ID
Fund Name DSC Equity Fund – Healthcare A
Fund Provider Dreyfus Söhne & Cie AG, Banquiers Aeschenvorstadt 16 | Postfach
4051 Basel
Schweiz
Phone: +41 61 286 66 66
Web: https://www.dreyfusbank.ch
Fund Provider Dreyfus Söhne & Cie AG, Banquiers
Representative in Switzerland Dreyfus Söhne & Cie AG, Banquiers
Basel
Distributor(s) Dreyfus Söhne & Cie AG, Banquiers
Basel
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Austria
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** N/A
Peculiarities

Fund Prices

Current Price * 194.83 CHF 11.04.2025
Previous Price * 198.94 CHF 10.04.2025
52 Week High * 239.85 CHF 03.09.2024
52 Week Low * 194.83 CHF 11.04.2025
NAV * 194.83 CHF 11.04.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 41,387,253
Unit/Share Assets *** 1,365,976
Trading Information SIX

Performance

YTD Performance -10.47% 30.12.2024
11.04.2025
1 month -13.89% 11.03.2025
11.04.2025
3 months -12.88% 14.01.2025
11.04.2025
6 months -15.96% 11.10.2024
11.04.2025
1 year -14.96% 11.04.2024
11.04.2025
2 years -11.55% 11.04.2023
11.04.2025
3 years -22.59% 11.04.2022
11.04.2025
5 years -3.37% 14.04.2020
11.04.2025

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

Eli Lilly and Co 7.98%
Johnson & Johnson 7.01%
UnitedHealth Group Inc 5.78%
Abbott Laboratories 5.05%
AbbVie Inc 4.51%
Merck & Co Inc 4.08%
AstraZeneca PLC 3.52%
Sanofi SA 3.42%
Intuitive Surgical Inc 3.27%
Novo Nordisk AS Class B 3.22%
Last data update 28.02.2025

Cost / Risk

TER 1.53%
TER date 30.04.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 1.52%
SRRI ***
SRRI date *** 31.03.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)